Publikationsserver der Universitätsbibliothek Marburg

Titel:Atrial remodelling in hypertensive heart disease: role of Na+ homeostasis and contractility
Autor:Nikonova Yulia
Weitere Beteiligte: Kockskämper, Jens (Prof.Dr.)
Veröffentlicht:2016
URI:https://archiv.ub.uni-marburg.de/diss/z2016/0211
DOI: https://doi.org/10.17192/z2016.0211
URN: urn:nbn:de:hebis:04-z2016-02113
DDC: Medizin
Titel (trans.):Atriales Remodelling bei hypertensiver Herzerkrankung: die Rolle der Na+-Homöostase und der Kontraktilität
Publikationsdatum:2016-06-08
Lizenz:https://creativecommons.org/licenses/by-nc-sa/4.0

Dokument

Schlagwörter:
atrial remodelling, heart failure, Vorhofflimmern, Herzinsuffizienz, atrial fibrillation, hypertension, Vorhof, Natrium, sodium homeostasis

Summary:
Arterial hypertension causes hypertensive heart disease. Constant mechanical stress and activation of neurohormonal systems cause structural and functional changes in the myocardium termed “remodelling”. Remodelling is beneficial in the beginning of the disease development; however, with time it becomes detrimental and impairs cardiac function. Remodelling of the myocardium occurs in hypertension, atrial fibrillation and heart failure. These cardiac diseases are tightly linked by the mechanisms of pathological remodelling and induce development and maintenance of one another. Ventricular remodelling has been studied intensively in hypertensive heart disease, however, atrial remodelling has been studied much less and is only poorly understood. Physiology of cardiac myocytes relies on balanced intracellular Na+ homeostasis. Na+ is involved in many cellular processes, such as action potential initiation, Ca2+ homeostasis, intracellular pH, metabolism and contractility. In the first part of the thesis I investigated ionic (Na+ homeostasis) and functional (contractility) atrial remodelling in an animal model of hypertensive heart disease – spontaneously hypertensive rats (SHR). In early hypertension, SHR exhibited elevated blood pressure and isolated left ventricular hypertrophy. The atria were not hypertrophied. Contractility of atrial myocytes and intracellular Na+ concentration ([Na+]i) were both unaltered. Expression of most Na+-handling proteins was unaffected in the atria of SHR. In advanced hypertension, SHR exhibited further progression of left ventricular hypertrophy and signs of heart failure. Left atria were hypertrophied. The contractility of atrial myocytes was reduced. [Na+]i was significantly decreased together with increased expression of the α 1 subunit of Na+/K+-ATPase. Expression of Na+/H+-exchanger was increased, suggesting activation of pro-hypertrophic pathways. Comparison of SHR with and without signs of heart failure (i.e. increased lung weight) revealed development of right ventricular hypertrophy and progression of bi-atrial hypertrophy in SHR with heart failure. Moreover, the impairment of atrial myocyte contractility progressed. However, [Na+]i and the expression of major Na+-handling proteins were not changed during the transition to heart failure. In addition to studies on atrial myocytes, we performed measurements of [Na+]i and contractility of ventricular myocytes from old SHR. In contrast to our findings in the atria, no impairment of contractility or changes in [Na+]i were observed in the ventricular myocytes, indicating atria-specific remodelling. Taken together, the presented results indicate that in early hypertension no significant signs of atrial remodelling in terms of contractility and Na+ homeostasis were found. However, in advanced hypertensive heart disease there was atria-specific functional atrial remodelling, which might contribute to the transition from compensated left ventricular hypertrophy to heart failure. Atrial ionic remodelling is an important factor in the development and maintenance of atrial fibrillation. The role of intracellular Na+ homeostasis in these processes is not understood. In the second part of the thesis, I investigated expression of Na+-handling proteins in right atrial tissue of patients suffering from paroxysmal and chronic atrial fibrillation compared to patients with sinus rhythm. The results indicated that the expression of Na+-handling proteins, including Na+ channels, Na+/H+ exchanger, alpha subunits of Na+/K+-ATPase, phospholemman, was not altered in either paroxysmal or chronic atrial fibrillation. The expression of β 1 subunit of Na+/K+-ATPase was significantly reduced in chronic atrial fibrillation. However, the functional consequences of this change require further investigation. Endothelin-1 plays an important role in the regulation of blood pressure and cardiac physiology. Enhancement of endothelin-1 system activity contributes to cardiac maladaptive remodelling, including disturbances in Ca2+ and Na+ homeostasis in cardiac myocytes. At the age of 7 months, SHR exhibit enhanced endothelin-1 signalling and altered Ca2+ handling. Therefore, in the third part of the thesis we investigated the effect of endothelin-1 receptor blockage on blood pressure and expression and phosphorylation of Ca2+-handling proteins, as well as the expression of proteins involved in endothelin-1 signalling in the atria of SHR. The results revealed that the blockage of endothelin receptors by 8 weeks treatment with macitentan (novel dual endothelin A and endothelin B receptor antagonist) did not lower blood pressure in SHR. Expression and phosphorylation of major Ca2+-handling proteins and endothelin-1 signalling proteins were both unaffected. Thus, the blockage of endothelin receptors did not cause any major changes in atrial Ca2+ remodelling in SHR

Bibliographie / References

  1. Jayachandran, J.V. et al., 2000. Atrial fibrillation produced by prolonged rapid atrial pacing is associated with heterogeneous changes in atrial sympathetic innervation. Circulation, 101(10), pp.1185–1191.
  2. Wang, T.J. et al., 2003. Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart Study. Circulation, 107(23), pp.2920–2925.
  3. Dodd, M.S. et al., 2012. In vivo alterations in cardiac metabolism and function in the spontaneously hypertensive rat heart. Cardiovascular Research, 95(1), pp.69–76.
  4. Workman, A.J., Kane, K.A. & Rankin, A.C., 2003. Characterisation of the Na, K pump current in atrial cells from patients with and without chronic atrial fibrillation. Cardiovascular Research, 59(3), pp.593–602.
  5. Plutenau F., Heß J., Nikonova Y., Plackic J., Kockskämper J., Atrial calcium handling in spontaneously hypertensive rats, Herbsttagung der Deutschen Gesellschaft für
  6. Lau, D.H. et al., 2013. Atrial arrhythmia in ageing spontaneously hypertensive rats: unraveling the substrate in hypertension and ageing. M. Rota, ed. PLoS ONE, 8(8), p.e72416.
  7. Avkiran, M., 2003. Basic biology and pharmacology of the cardiac sarcolemmal sodium/hydrogen exchanger. Journal of Cardiac Surgery, 18 Suppl 1, pp.3–12.
  8. Pavlovic, D., Fuller, W. & Shattock, M.J., 2013. Novel regulation of cardiac Na pump via phospholemman. Journal of Molecular and Cellular Cardiology, pp.1–11.
  9. 11. Publications 11.1. Original papers 2014
  10. Imahashi, K. et al., 2 0 0 7 . O v e r e x p r e s s i o n o f t h e N a + /H + exchanger and ischemia- reperfusion injury in the myocardium. AJP: Heart and Circulatory Physiology, 292(5), pp.H2237–H2247.
  11. Mancia, G. et al., 2014. 2013 ESH/ESC Practice Guidelines for the Management of Arterial Hypertension. Blood pressure, 23(1), pp.3–16.
  12. Rinne A., Kienitz M., Schä̈ fer M.K.-H., Weihe E., Goette A., Kockskämper J.,2015 Early subcellular Ca 2+ remodelling and increased propensity for Ca 2+ alternans in left atrial myocytes from hypertensive rats. Cardiovascular Research, 106 (1) pp. 87-97. 11.2. Abstracts and poster presentations 2011
  13. Millane, T. et al., 2000. ABC of heart failure. Acute and chronic management strategies. BMJ (Clinical research ed.), 320(7234), pp.559–562.
  14. Kockskämper, J. et al., 2001. Activation and Propagation of Ca 2+ R e l e ase during Excitation-Contraction Coupling in Atrial Myocytes. Biophysical Journal, 81(5), pp.2590–2605.
  15. Pluteanu F., Preisenberger J., Heß J., Nikonova Y., Plackic J., Kockskämper J., Altered Ca 2+ homeostasis and Ca 2+ alternans in left atrial myocytes of spontaneously hypertensive rats, 58 th annual Biophysical society meeting, San-Francisco, California, USA, 15.02.14-18.02.14
  16. Swift, F. et al., 2008. Altered Na + /Ca 2+ -exchanger activity due to downregulation of Na + /K + -ATPase α2-isoform in heart failure. Cardiovascular Research, 78(1), pp.71– 78.
  17. Sossalla, S. et al., 2010. Altered Na + Currents in Atrial Fibrillation. JAC, 55(21), pp.2330– 2342.
  18. Schussheim, A. & Radda, G., 1995. Altered Na + -H + -exchange activity in the spontaneously hypertensive perfused rat heart. Journal of Molecular and Cellular Cardiology, 27(8), pp.1475–1481.
  19. Nishikibe, M. et al., 1993. Antihypertensive effect of a newly synthesized endothelin antagonist, BQ-123, in a genetic hypertensive model. Life Sciences, 52(8), pp.717– 724.
  20. Pluteanu, F. et al., 2013. Atrial endothelin-1 signalling in hypertensive rats. European Heart Journal, 34 (suppl 1), P5040-5040. References 146
  21. Wijesurendra, R.S. & Casadei, B., 2015. Atrial fibrillation: effects beyond the atrium? Cardiovascular Research, 105(3), pp.238–247.
  22. Maisel, W.H. & Stevenson, L.W., 2003. Atrial fibrillation in heart failure: epidemiology, pathophysiology, and rationale for therapy. The American journal of cardiology, 91(6), pp.2–8.
  23. Korantzopoulos, P., Kolettis, T. & Goudevenos, J., 2003. Atrial fibrillation in hypertension: an established association with several unresolved issues. Cardiology, 100(2), pp.105–106.
  24. van Bragt, K.A. et al., 2014. Atrial supply-demand balance in healthy adult pigs: coronary blood flow, oxygen extraction, and lactate production during acute atrial fibrillation. Cardiovascular Research, 101(1), pp.9–19. References 148
  25. Zhu, W. et al., 2000. Ca 2+ /calmodulin-dependent kinase II and calcineurin play critical roles in endothelin-1-induced cardiomyocyte hypertrophy. Journal of Biological Chemistry, 275(20), pp.15239–15245.
  26. Neef, S. et al., 2010. CaMKII-dependent diastolic SR Ca 2+ leak and elevated diastolic Ca 2+ levels in right atrial myocardium of patients with atrial fibrillation. Circulation Research, 106(6), pp.1134–1144.
  27. Pfeffer, J.M. et al., 1979. Cardiac function and morphology with aging in the spontaneously hypertensive rat. The American journal of physiology, 237(4), pp.H461–8.
  28. Aronsen, J.M., Swift, F. & Sejersted, O.M., 2013. Cardiac sodium transport and excitation– contraction coupling. Journal of Molecular and Cellular Cardiology, 61,pp.11–19.
  29. Ito, S., Ohta, T. & Nakazato, Y., 1997. Changes in intracellular Na + concentration evoked by nicotinic receptor activation in the guinea-pig adrenal chromaffin cells. Neuroscience letters, 238(3), pp.111–114.
  30. Jayachandran, V. et al., 1998. Chronic atrial fibrillation from rapid atrial pacing is associated with reduced atrial blood flow: A positron emission tomography study. Circulation, 98(17), pp.209–209.
  31. Smyrnias, I. et al., 2010. Comparison of the T-tubule system in adult rat ventricular and atrial myocytes, and i t s r o l e i n e x c i t a t i o n -contraction coupling and inotropic stimulation. Cell Calcium, 47(3), pp.210–223.
  32. Lee, S.W. et al., 1983. Decrease in Na + ,K + -ATPase activity and [3H]ouabain binding sites in sarcolemma prepared from hearts of spontaneously hypertensive rats. Hypertension, 5(5), pp.682–688.
  33. January, C.T. & Fozzard, H.A., 1988. Delayed afterdepolarizations in heart muscle: mechanisms and relevance. Pharmacological Reviews, 40(3), pp.219–227.
  34. Okamoto, K. & Aoki, K., 1963. Development of a strain of spontaneously hypertensive rats. Japanese circulation journal, 27, pp.282–293.
  35. Asai, T. et al., 2005. Different effects on inhibition of cardiac hypertrophy in spontaneously hypertensive rats by monotherapy and combination therapy of adrenergic receptor antagonists and/or the angiotensin II type 1 receptor blocker under comparable blood pressure reduction. Hypertension research : official journal of the Japanese Society of Hypertension, 28(1), pp.79–87.
  36. Kaufmann, S.G. et al., 2013. Distribution and function of sodium channel subtypes in human atrial myocardium. Journal of Molecular and Cellular Cardiology, pp.1–9.
  37. Yono, M. et al., 2004. Doxazosin treatment causes differential alterations of alpha 1- adrenoceptor subtypes in the rat kidney, heart and aorta. Life Sciences, 75(21), pp.2605–2614.
  38. Zeng, J. & Rudy, Y., 1995. Early afterdepolarizations in cardiac myocytes: mechanism and rate dependence. Biophysical Journal, 68(3), pp.949–964.
  39. Pluteanu, F. et al., 2015. Early subcellular Ca 2+ remodelling and increased propensity for Ca 2+ alternans in left atrial myocytes from hypertensive rats. Cardiovascular Research, 106(1), pp.87–97.
  40. Li, J.S. & Schiffrin, E.L., 1995. Effect of chronic treatment of adult spontaneously hypertensive rats with an endothelin receptor antagonist. Hypertension, 25(4 Pt 1), pp.495–500.
  41. Orchard, C.H. & Kentish, J.C., 1990. Effects of Changes of pH on the Contractile Function of Cardiac-Muscle. The American journal of physiology, 258(6), pp.C967–C981.
  42. Pluteanu F., Kiess T., Sack C., Nikonova Y., Plackic J., Roderick H.L., Kockskämper J., Endothelin-1 alters calcium transients in atrial myocytes from spontaneously hypertensive rats, 91. Jahrestagung der Deutschen Physiologischen Gesellschaft e.V., Dresden, Germany, 22.03.12-25.03.12
  43. Aiello, E.A. et al., 2005. Endothelin-1 stimulates the Na + /Ca 2+ exchanger reverse mode through intracellular Na + ( N a + i)-dependent and Na + i-independent pathways. Hypertension, 45(2), pp.288–293.
  44. Thibault, G. et al., 1994. Endothelin-stimulated secretion of natriuretic peptides by rat atrial myocytes is mediated by endothelin A receptors. Circulation Research, 74(3), pp.460–470.
  45. Schotten, U. et al., 2010. Enhanced Late Na + Currents in Atrial Fibrillation. JAC, 55(21), pp.2343–2345.
  46. Voigt, N. et al., 2012. Enhanced sarcoplasmic reticulum Ca 2+ leak and increased Na + -Ca 2+ exchanger function underlie delayed afterdepolarizations in patients with chronic atrial fibrillation. Circulation, 125(17), pp.2059–2070.
  47. Kaye, D.M. & Kelly, R.A., 1999. Expression and regulation of the sodium-calcium exchanger in cardiac microvascular endothelial cells. Clinical and Experimental Pharmacology and Physiology, 26(8), pp.651–655.
  48. Jäger, H. et al., 2001. Expression of sodium pump isoforms and other sodium or calcium ion transporters in the heart of hypertensive patients. Biochimica et biophysica acta, 1513(2), pp.149–159.
  49. Minta, A. & Tsien, R.Y., 1989. Fluorescent indicators for cytosolic sodium. Journal of Biological Chemistry, 264(32), pp.19449–19457.
  50. Despa, S. & Bers, D.M., 2007. Functional analysis of Na + /K + -ATPase isoform distribution in rat ventricular myocytes. AJP: Cell Physiology, 293(1), pp.C321–C327.
  51. Vanecková, I., 2002. Function of the isolated perfused kidney in young and adult spontaneously hypertensive and dahl salt-sensitive rats. Kidney & blood pressure research, 25(5), pp.315–321.
  52. Shah, A.M. & Lam, C.S.P., 2014. Function over form? Assessing the left atrium in heart failure. European Heart Journal, 36(12), pp.711-714.
  53. Diamond, J.A. & Phillips, R.A., 2005. Hypertensive Heart Disease. Hypertension research : official journal of the Japanese Society of Hypertension, 28(3), pp.191–202.
  54. van der Velden, J. et al., 2003. Increased Ca 2+ -sensitivity of the contractile apparatus in end-stage human heart failure results from altered phosphorylation of contractile proteins. Cardiovascular Research, 57(1), pp.37–47.
  55. Rodriguez, J.S. et al., 2014. Increased Na⁺/Ca²⁺ exchanger expression/activity constitutes a point of inflection in the progression to heart failure of hypertensive rats. N.
  56. Baartscheer, A., 2003. Increased Na + /H + -exchange activity is the cause of increased [Na + ]i and underlies disturbed calcium handling in the rabbit pressure and volume overload heart failure model. Cardiovascular Research, 57(4), pp.1015–1024.
  57. Diarra, A., Sheldon, C. & Church, J., 2001. In situ calibration and [H + ] sensitivity of the fluorescent Na + indicator SBFI. AJP: Cell Physiology, 280(6), pp.C1623–33.
  58. Akar, J.G. et al., 2003. Intracellular chloride accumulation and subcellular elemental distribution during atrial fibrillation. Circulation, 107(13), pp.1810–1815.
  59. Despa, S., 2002. Intracellular Na + Concentration Is Elevated in Heart Failure But Na/K Pump Function Is Unchanged. Circulation, 105(21), pp.2543–2548.
  60. Vaughan-Jones, R.D., Spitzer, K.W. & Swietach, P., 2009. Intracellular pH regulation in heart. Journal of Molecular and Cellular Cardiology, 46(3), pp.318–331.
  61. Tsukamoto, O. & Kitakaze, M., 2013. It is time to reconsider the cardiovascular protection afforded by RAAS blockade -- overview of RAAS systems. Cardiovascular Drugs and Therapy, 27(2), pp.133–138.
  62. Kerkelä, R. et al., 2011. Key roles of endothelin-1 and p38 MAPK in the regulation of atrial stretch response. American journal of physiology. Regulatory, integrative and comparative physiology, 300(1), pp.R140–9.
  63. Scridon, A. et al., 2013. Left atrial endocardial fibrosis and intra-atrial thrombosis - landmarks of left atrial remodeling in rats with spontaneous atrial tachyarrhythmias. Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie, 54(2), pp.405–411.
  64. Noresson, E., Ricksten, S.E. & Thoren, P., 1979. Left atrial pressure in normotensive and spontaneously hypertensive rats. Acta physiologica Scandinavica, 107(1), pp.9–12.
  65. Benjamin, E.J. et al., 1995. Left Atrial Size and the Risk of Stroke and Death : The Framingham Heart Study. Circulation, 92(4), pp.835–841. References 139
  66. Kahan, T. & B e r g f e l d t , L . , 2 0 0 5 . L e f t v e n t r i c u l a r h y p e r t r o p h y i n h y p e r t e n s i o n : i t s arrhythmogenic potential. Heart (British Cardiac Society), 91(2), pp.250–256.
  67. Slama, M. et al., 2004. Long-term left ventricular echocardiographic follow-up of SHR and WKY rats: effects of hypertension and age. AJP: Heart and Circulatory Physiology, 286(1), pp.H181–5.
  68. Varagic, J., Susic, D. & Frohlich, E.D., 2001. Low-dose ACE with alpha- or beta-adrenergic receptor inhibitors have beneficial SHR cardiovascular effects. Journal of cardiovascular pharmacology and therapeutics, 6(1), pp.57–63.
  69. Díez, J., 2007. Mechanisms of Cardiac Fibrosis in Hypertension. The Journal of Clinical Hypertension, 9(7), pp.546–550.
  70. Kranias, E.G. & Hajjar, R.J., 2012. Modulation of cardiac contractility by the phospholamban/SERCA2a regulatome. Circulation Research, 110(12), pp.1646– 1660.
  71. Shattock, M.J. et al., 2015. Na + /Ca 2+ exchange and Na + /K + -ATPase in the heart. The Journal of Physiology, 593(6), pp.1361–1382.
  72. Pieske, B. & Houser, S.R., 2003. [Na + ]i handling in the failing human heart. Cardiovascular Research, 57(4), pp.874–886.
  73. Zahler, R. et al., 1996. Na-K-ATPase alpha-isoform expression in heart and vascular endothelia: cellular and developmental regulation. AJP: Cell Physiology, 270(1), pp.C361–C371.
  74. Despa, S. & Bers, D.M., 2013. Na + transport in the normal and failing heart — Remember the balance. Journal of Molecular and Cellular Cardiology, pp.1–9.
  75. Dobrev, D. & Nattel, S., 2010. New antiarrhythmic drugs for treatment of atrial fibrillation. The Lancet, 375(9721), pp.1212–1223.
  76. Malkoff, J., 2005. Non-invasive blood pressure for mice and rats. Animal Lab News.
  77. Wikberg, J. et al., 1983. Norepinephrine-Induced Down Regulation of Alpha-1- Adrenergic Receptors in Cultured Rabbit Aorta Smooth-Muscle Cells. Life Sciences, 33(14), pp.1409–1417.
  78. Jelicks, L.A. & Gupta, R.K., 1994. Nuclear-Magnetic-Resonance Measurement of Intracellular Sodium in the Perfused Normotensive and Spontaneously Hypertensive Rat-Heart. American journal of hypertension, 7(5), pp.429–435.
  79. Correll, R.N. et al., 2014. Overexpression of the Na + /K + ATPase 2 But Not 1 Isoform Attenuates Pathological Cardiac Hypertrophy and Remodeling. Circulation Research, 114(2), pp.249–256.
  80. Weber, K.T. & Brilla, C.G., 1991. Pathological hypertrophy and cardiac interstitium. Fibrosis and renin-angiotensin-aldosterone system. Circulation, 83(6), pp.1849–1865.
  81. Schotten, U. et al., 2011. Pathophysiological mechanisms of atrial fibrillation: a translational appraisal. Physiological reviews, 91(1), pp.265–325.
  82. Shanks, J. & Herring, N., 2013. Peripheral cardiac sympathetic hyperactivity in cardiovascular disease: role of n e u r o p e p t i d e s . AJP: Regulatory, Integrative and Comparative Physiology, 305(12), pp.R1411–R1420.
  83. Katz, A.M., 2010. Physiology of the Heart. : Lippincott Williams &Wilkins; 2010, p.475.
  84. Levi, A.J., Lee, C.O. & Brooksby, P., 1994. Properties of the fluorescent sodium indicator " SBFI " in rat and rabbit cardiac myocytes. Journal of Cardiovascular Electrophysiology, 5(3), pp.241–257.
  85. Doggrell, S.A. & Brown, L., 1998. Rat models of hypertension, cardiac hypertrophy and failure. Cardiovascular Research, 39(1), pp.89–105.
  86. Ward, M.L. et al., 2003. Reduced contraction strength with increased intracellular [Ca 2+ ] in left ventricular trabeculae from failing rat hearts. The Journal of Physiology, 546(2), pp.537–550.
  87. Schwinger, R.H.G. et al., 1999. Reduced Sodium Pump 1, 3, and 1-Isoform Protein Levels and Na + ,K + -ATPase Activity but Unchanged Na + -Ca 2+ E x c h a n g e r P r o t e i n Levels in Human Heart Failure. Circulation, 99(16), pp.2105–2112.
  88. Muller-Ehmsen, J. et al., 2001. Region specific regulation of sodium pump isoform and Na,Ca-exchanger expression in the failing human heart--right atrium vs left ventricle. Cellular and molecular biology (Noisy-le-Grand, France), 47(2), pp.373–381.
  89. Layland, J., Solaro, R.J. & Shah, A.M., 2005. Regulation of cardiac contractile function by troponin I phosphorylation. Cardiovascular Research, 66(1), pp.12–21.
  90. Avkiran, M. & Haworth, R.S., 1999. Regulation of cardiac sarcolemmal Na + /H + exchanger activity by endogenous ligands. Relevance to ischemia. Annals of the New York Academy of Sciences, 874, pp.335–345.
  91. Wakabayashi, S., Hisamitsu, T. & Nakamura, T.Y., 2013. Regulation of the cardiac Na + /H + exchanger in health and disease. Journal of Molecular and Cellular Cardiology, 61(C), pp.68–76.
  92. Avkiran, M. & Haworth, R.S., 2003. Regulatory effects of G protein-coupled receptors on cardiac sarcolemmal Na + /H + e x c h a n g e r a c t i v i t y : s i g n a l l i n g a n d s i g n i f i c a n c e . Cardiovascular Research, 57(4), pp.942–952.
  93. Maixent, J.-M. et al., 2002. Remodeling of Na,K-ATPase, and membrane fluidity after atrial fibrillation in sheep. Journal of receptor and signal transduction research, 22(1- 4), pp.201–211.
  94. Patel, M.R. et al., 2011. Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation. New England Journal of Medicine, 365(10), pp.883–891.
  95. Seravalle, G., Mancia, G. & Grassi, G., 2014. Role of the sympathetic nervous system in hypertension and hypertension-related cardiovascular disease. High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension, 21(2), pp.89–105.
  96. Trippodo, N.C. & Frohlich, E.D., 1981. Similarities of genetic (spontaneous) hypertension. Man and rat. Circulation Research, 48(3), pp.309–319.
  97. Vrbjar, N. et al., 2002. Sodium and ATP affinities of the cardiac Na + ,K + -ATPase in spontaneously hypertensive rats. General Physiology and Biophysics, 21(3), pp.303– 313.
  98. Baartscheer, A. & van Borren, M., 2008. Sodium Ion Transporters as New Therapeutic Targets in Heart Failure. Cardiovascular & Hematological Agents in Medicinal Chemistry, 6(4), pp.229–236.
  99. David, G., Barrett, J.N. & Barrett, E.F., 1997. Spatiotemporal gradients of intra-axonal [Na + ] after transection and resealing in lizard peripheral myelinated axons. The Journal of Physiology, 498(2), pp.295–307.
  100. Lee, B.L., Sykes, B.D. & Fliegel, L., 2012. Structural and functional insights into the cardiac Na + /H + exchanger. Journal of Molecular and Cellular Cardiology, pp.1–8.
  101. Walker , J.M. 1994. The bicinchonic acid (BCA) assay for protein quantification. Methods in Molecular Biology, 32, pp. 5-8.
  102. Andrade, J. et al., 2014. The clinical profile and pathophysiology of atrial fibrillation: relationships among clinical features, epidemiology, and mechanisms. Circulation Research, 114(9), pp.1453–1468.
  103. Krum, H. et al., 1998. The Effect of an Endothelin-Receptor Antagonist, Bosentan, on Blood Pressure in Patients with Essential Hypertension. New England Journal of Medicine, 338(12), pp.784–791.
  104. Kahan, T., 1998. The importance of left ventricular hypertrophy in human hypertension. Journal of hypertension. Supplement : official journal of the International Society of Hypertension, 16(7), pp.S23–9.
  105. Johnson, I. & Spence, M., 2010. The molecular probes handbook. :Life Technologies Corporation; 2010, pp.835-836, p.881, pp.905-906.
  106. Karmazyn, M. et al., 1999. The myocardial Na + -H + exchange: structure, regulation, and its role in heart disease. Circulation Research, 85(9), pp.777–786. References 143
  107. Kemp, C.D. & Conte, J.V., 2012. The pathophysiology of heart failure. Cardiovascular Pathology, 21(5), pp.365–371.
  108. Levy, D. et al., 1996. The Progression From Hypertension to Congestive Heart Failure. JAMA, 275(20), pp.1557–1562.
  109. Drazner, M.H., 2011. The progression of hypertensive heart disease. Circulation, 123(3), pp.327–334. References 142
  110. Kodavanti, U.P. et al., 2000. The Spontaneously Hypertensive Rat as a Model of Human Cardiovascular Disease: Evidence of Exacerbated Cardiopulmonary Injury and Oxidative Stress from Inhaled Emission Particulate Matter. Toxicology and Applied Pharmacology, 164(3), pp.250–263.
  111. Triposkiadis, F. et al., 2009. The Sympathetic Nervous System in Heart Failure. JAC, 54(19), pp.1747–1762.
  112. Schägger, H., 2006. Tricine-SDS-PAGE. Nature Protocols,1 (1), pp.16-22.
  113. Solaro, R.J. & Rarick, H.M., 1998. Troponin and Tropomyosin Proteins That Switch on and Tune in the Activity of Cardiac Myofilaments. Circulation Research, 83(5), pp.471–480.
  114. Scridon, A. et al., 2012. Unprovoked atrial tachyarrhythmias in aging spontaneously hypertensive rats: the role of the autonomic nervous system. AJP: Heart and Circulatory Physiology, 303(3), pp.H386–H392.
  115. Walther S., Pluteanu F., Renz S., Nikonova Y., Maxwell J.T., Yang L., Schmidt K., Edwards J.N., Wakula P., Groschner K., Maier L.S., Spiess J., Blatter L.A., Pieske B., Kockskämper J., 2014, Urocortin stimulates nitric oxide production in ventricular myocytes via Akt-and PKA-mediated phosphorylation of eNOS at serine 1177. AJP: Heart and Circulatory Physiology, 307(5), pp.H689–H700 2015
  116. McLenachan, J.M. et al., 1987. Ventricular Arrhythmias in Patients with Hypertensive Left Ventricular Hypertrophy. New England Journal of Medicine, 317(13), pp.787– 792.
  117. Swedberg, K. et al., 2005. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005). European Heart Journal, 26(11), pp.1115–1140.
  118. O'Connell, T.D. et al., 2014. Cardiac alpha1-adrenergic receptors: novel aspects of expression, signaling mechanisms, physiologic function, and clinical importance. Pharmacological Reviews, 66(1), pp.308–333.
  119. Wendt Gallitelli, M.F., Voigt, T. & Isenberg, G., 1993. Microheterogeneity of subsarcolemmal sodium gradients. Electron probe microanalysis in guinea-pig ventricular myocytes. The Journal of Physiology, 472(1), pp.33–44.
  120. Donoso, P., Mill, J.G., O'Neill, S.C. & Eisner, D.A., 1992. Fluorescence measurements of cytoplasmic and mitochondrial sodium concentration in rat ventricular myocytes. The Journal of Physiology, 448(1), pp.493–509.
  121. Despa, S. et al., 2004. Na/K Pump-Induced [Na]i Gradients in Rat Ventricular Myocytes Measured with Two-Photon Microscopy. Biophysical Journal, 87(2), pp.1360–1368.
  122. Zhang, L. et al., 2002. Alpha-1 adrenoceptor up-regulation induced by prazosin but not KMD-3213 or reserpine in rats. British Journal of Pharmacology, 135(7), pp.1757– 1764.
  123. Jessup, J.A., Brosnihan, K.B., et al., 2008. Differential effect of low-dose thiazides on the renin angiotensin system in genetically hypertensive and normotensive rats. Journal of the American Society of Hypertension, 2(2), pp.106–115.
  124. Kockskämper, J., Lewinski, von, D., et al., 2008. The slow force response to stretch in atrial and ventricular myocardium from human heart: Functional relevance and subcellular mechanisms. Progress in Biophysics and Molecular Biology, 97(2-3), pp.250–267.
  125. Jessup, J.A., Trask, A.J., et al., 2008. Localization of the novel angiotensin peptide, angiotensin-(1-12), in heart and kidney of hypertensive and normotensive rats. AJP: Heart and Circulatory Physiology, 294(6), pp.H2614–H2618.
  126. Kohlhaas, M. et al., 2010. Elevated Cytosolic Na + Increases Mitochondrial Formation of Reactive Oxygen Species in Failing Cardiac Myocytes. Circulation, 121(14), pp.1606– 1613.
  127. Kapur, S. et al., 2010. Early development of intracellular calcium cycling defects in intact hearts of spontaneously hypertensive rats. AJP: Heart and Circulatory Physiology, 299(6), pp.H1843–H1853.
  128. Mayyas, F. et al., 2010. Association of left atrial endothelin-1 with atrial rhythm, size, and fibrosis in patients with structural heart disease. Circulation: Arrhythmia and Electrophysiology, 3(4), pp.369–379.
  129. Wakili, R. et al., 2011. Recent advances in the molecular pathophysiology of atrial fibrillation. Journal of Clinical Investigation, 121(8), pp.2955–2968.
  130. Anderson, M.E., Brown, J.H. & Bers, D.M., 2011. CaMKII in myocardial hypertrophy and heart failure. Journal of Molecular and Cellular Cardiology, 51(4), pp.468–473.
  131. Louch, W.E., Sheehan, K.A. & Wolska, B.M., 2011. Methods in cardiomyocyte isolation, culture, and gene transfer. Journal of Molecular and Cellular Cardiology, 51(3), pp.288–298.
  132. Drawnel, F.M., Archer, C.R. & Roderick, H.L., 2013. The role of the paracrine/autocrine mediator endothelin-1 in regulation of cardiac contractility and growth. British Journal of Pharmacology, 168(2), pp.296–317.
  133. Kholdani, C.A., Fares, W.H. & Trow, T.K., 2014. Macitentan for the treatment of pulmonary arterial hypertension. Vascular health and risk management, 10, pp.665– 673.
  134. Anter, E., Jessup, M. & Callans, D.J., 2009. Atrial fibrillation and heart failure: treatment considerations for a dual epidemic. Circulation, 119(18), pp.2516–2525.
  135. Pogwizd, S., 2003. Intracellular Na in animal models of hypertrophy and heart failure: contractile function and arrhythmogenesis. Cardiovascular Research, 57(4), pp.887– 896.
  136. Kockskämper, J., Zima, A.V., et al., 2008. Emerging roles of inositol 1,4,5-trisphosphate signaling in cardiac myocytes. Journal of Molecular and Cellular Cardiology, 45(2), pp.128–147.


* Das Dokument ist im Internet frei zugänglich - Hinweise zu den Nutzungsrechten